Central nervous system toxicity of sodium nitroprusside in treatment of patients with aortic dissection

Abstract

This study examined the sodium nitroprusside (SNP) toxicity to central nervous system (CNS) in treatment of patients with aortic dissection (AD). The medical records of 191 AD patients who were admitted to Tongji Hospital, China, from Jan. 1998 to Feb. 2009 were retrospectively analyzed. There were 140 cases of hypertension (73.3%) and 13 cases of Marfan syndrome (6.8%) among the 191 AD patients. A total of 157 patients were given SNP treatment. The toxic reactions of CNS occurred in 18 subjects (11.5%). Most of the adverse reactions occurred on the fifth day following SNP injection. SNP infusion rate was significantly higher in patients who developed CNS toxicity. It was suggested that systemic hypertension is the most common predisposing factor for AD. The combination of SNP with a β-receptor blocker is a medical therapy commonly used in patients with AD. Cyanide and thiocyanate toxicity from SNP treatment is always the consequence of prolonged drug infusion or relatively high dose administration.

Keywords

sodium nitroprusside / toxicity / central nervous system / aortic dissection

References

[1] OlssonC., ThelinS., StahleE., et al.. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation, 2006, 114(24): 2611-2618

[2] HaganP.G., NienableC.A., IsselacherE.M., et al.. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA, 2000, 283(7): 897-903

[3] GolledgeJ., EagleK.A.. Acute aortic dissection. Lancet, 2008, 372(9632): 55-66

[4] FeldmanM., ShahM., ElefteriadesJ.A.. Medical management of acute type aortic dissecton. Ann thorac Cardiovasc Surg, 2009, 15(5): 286-293

[5] RampoldiV., TrimarchiS., EagleK.A., et al.. Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score. Ann Thorac Surg, 2007, 83(1): 55-61

[6] SvenssonL.G., KouchoukosN.T., MillerD.C.. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg, 2008, 85(1Suppl): S1-41

[7] FlecherE., CluzelP., BonnetN., et al.. Endovascular treatment of descending aortic dissection (type B): short- and medium-term results. Arch Cardiovasc Dis, 2008, 101(2): 94-99

[8] EggebrechtH., NienaberC.A., NeuhauserM., et al.. Endovascular stent-graft placement in aortic dissection: a meta-analysis. Eur Heart J, 2006, 27(4): 489-498

[9] ParkerJ.D., GolledgeJ.. Outcome of endovascular treatment of acute type B aortic dissection. Ann Thorac Surg, 2008, 86(5): 1707-1712

[10] HaasA.R., MarikP.E.. Current diagnosis and management of hypertensive emergency. Semin Dial, 2006, 19(6): 502-512

[11] VaronJ., MarikP.E.. Clinical review: the management of hypertensive crises. Critical Care, 2003, 7(5): 374-384

[12] MarikP.E., VaronJ.. Hypetensive crises-challenges and management. Chest, 2007, 131(6): 1949-1962

[13] VeseyC.J., ColeP.V., SimpsonP.J.. Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth, 1976, 48(7): 651-660

[14] RobinE.D., McCauleyR.. Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions. Chest, 1992, 102(6): 1842-1845

[15] JohanningR.J., ZaskeD.E., TschidaS.J., et al.. A retrospective study of sodium nitroprusside use and assessment of the potential risk of cyanide poisoning. Pharmacotherapy, 1995, 15(6): 773-777

[16] RindoneJ.P., SloaneE.P.. Cyanide toxicity from sodium nitroprusside: risks and management. Ann Pharmacother, 1992, 26(4): 515-519

[17] FriederichJ.A., ButterworthJ.F.IV. Sodium nitroprusside: twenty years and counting. Anesth Analg, 1995, 81(1): 152-162

[18] SweetmanS.C.. . Martindale: The Complete Drug Reference, 200936th edLondon, The Pharmaceutical Press, 1397